Integrated Wealth Concepts’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Integrated Wealth Concepts’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.2K	Buy	+450	New	+$15.7K	﹤0.01%	4199

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Integrated Wealth Concepts's FTXH Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2026: 450 shares worth $17.2K. The stake represents ﹤0.01% of the portfolio and ranks #4199 among its holdings.

31 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Integrated Wealth Concepts held 450 shares of First Trust Nasdaq Pharmaceuticals ETF worth $17.2K as of Q2 2026.
First Trust Nasdaq Pharmaceuticals ETF was a new Integrated Wealth Concepts position in Q2 2026.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4199 holding.
31 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.